6 research outputs found
sj-docx-1-tam-10.1177_17588359241236450 – Supplemental material for Histological sarcomatoid transformation in a lung adenocarcinoma patient following immune checkpoint blockade
Supplemental material, sj-docx-1-tam-10.1177_17588359241236450 for Histological sarcomatoid transformation in a lung adenocarcinoma patient following immune checkpoint blockade by Xiuju Liang, Yaping Guan, Baocheng Wang, Xiaohong Liu and Jun Wang in Therapeutic Advances in Medical Oncology</p
Kaplan-Meier survival curves for NSCLC patients in relation to pathologic stage and NLR.
<p><i>P</i> values were determined by the log-rank test. (A) Distant recurrence-free survival, (B) disease-specific survival, and (C) overall survival. Patients with high NLR had shorter OS compared to those with low NLR with stage I disease (<i>P</i> = 0.005). Patients with high NLR had both DSS and OS shorter than those in patients with low NLR in stage II disease (<i>P</i> = 0.005 and 0.032, respectively).</p
Multivariable analysis of independent prognostic factors for survival in patients with stage I-III NSCLC.
<p>Multivariable analysis of independent prognostic factors for survival in patients with stage I-III NSCLC.</p
Clinicopathological features and NLR in NSCLC.
<p>Clinicopathological features and NLR in NSCLC.</p
Association of pretreatment NLR with survival in NSCLC.
<p>All possible cut-off values for NLR and their impact on RFS (A) or OS (B) are depicted for the whole study cohort. The hazard ratio (HR) including 95% CI is plotted in dependence of the cutoff. A vertical line designates the dichotomization showing the most significant correlation with survival.</p
Univariate survival analysis (Kaplan-Meier) on LRFS, DRFS, RFS, OS and DSS in selected subgroups of patients according to characteristics.
<p>Univariate survival analysis (Kaplan-Meier) on LRFS, DRFS, RFS, OS and DSS in selected subgroups of patients according to characteristics.</p